a Policy Unit, the Wellcome Trust, 210 Euston Road, London NW1 2BE, UK, b Department of Gastroenterology and Hepatology, Academisch Ziekenhuis Groningen, Hanzeplein 1, Postbus 30.001, 9700 RB ...

Introduction The Joint Advisory Group (JAG) ISREE initiative in 2019 called for an improvement of safety in endoscopy, one of the recommendations was simulation training for staff. Endoscopy ...

Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic liver disease globally and is currently estimated to affect up to 38% of the global adult population. NAFLD is a ...

Objective Autophagy participates in the progression of hepatocellular carcinoma (HCC) and the resistance of HCC cells to sorafenib. We investigated the feasibility of sensitising HCC cells to ...

1 Institute of Biomedical and Clinical Sciences, St James’s University Hospital, University of Leeds, Leeds, UK 4 Institute of Cancer and Pathology, St James’s University Hospital, University of Leeds ...

We have studied 22 consecutive patients referred for investigation of severe chronic right upper quadrant pain. The majority were women whose symptoms had been present for many years. All had ...

Objective Early-onset colorectal cancer (CRC) is increasing in the USA despite rapid declines in older ages. Similar patterns are reported in Australia and Canada, but a comprehensive global analysis ...

Correspondence to Dr Citadel J Cabasag, Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France; cabasagc{at}fellows.iarc.fr We read with interest the commentary by ...

Objective Live biotherapeutic products (LBPs) are biological products composed of living micro-organisms, developed to ...

Over the past few decades, the prevalence of chronic inflammatory and metabolic diseases has risen sharply, coinciding with significant environmental and lifestyle changes. While genetics play a role, ...

We read with great interest the article by Cai et al ,1 titled ‘Construction of exosome non-coding RNA feature for ...

RNA-based therapeutics have rapidly emerged over the past decade, offering a new class of medicines that differ significantly from conventional drugs. These therapies can be programmed to target or ...